Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), a world leader in spider silk technology*, announces that senior management will travel to Southeast Asia this week to oversee the continued expansion of the Company’s recombinant spider silk production operations.
This strategic visit is designed to support and accelerate the Company’s 2025 production scale-up. In addition to reinforcing partnerships with current production collaborators, Kraig Labs leadership will evaluate options to onboard additional rearing capacity, including private partnerships and potential collaborations to further expand its manufacturing footprint.
This trip was scheduled in coordination with Dr. Nirmal Kumar, the Company’s lead sericulture expert. Dr. Kumar’s expertise and guidance have been instrumental in developing and executing the Company’s production expansion initiatives and optimizing the deployment of its proprietary spider silk technologies in the field.
In addition to meetings with key partners, senior management will review current spider silk inventories in preparation for anticipated shipments to strategic customers later this year. This review highlights the Company’s commitment to upholding high standards of quality and readiness as it progresses toward fulfilling commercial orders.
“Our continuing expansion in Southeast Asia has been one of the highlights of this year,” said Jon Rice, COO of Kraig Labs. “This trip will build on that success, allowing management to work side-by-side with our team and partners to continue strengthening the future of spider silk production. We are incredibly proud of what we’ve accomplished so far in 2025, and we look forward to taking the next steps during this trip to grow production and prepare for the upcoming commercial deliveries.”
The Company’s momentum in scaling up production reflects its broader mission to bring sustainable, high-performance spider silk materials to market and establish a robust commercial supply chain.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk-based fiber technologies.
The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.
Source: https://www.morningstar.com/